We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.5B
AUM Growth
+$193M
Cap. Flow
-$192M
Cap. Flow %
-1.67%
Top 10 Hldgs %
54.02%
Holding
1,049
New
36
Increased
599
Reduced
353
Closed
55

Sector Composition

Rank Sector Weight
1 Energy 64.17%
2 Technology 5.57%
3 Healthcare 3.84%
4 Consumer Discretionary 3.76%
5 Financials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
526
O'Reilly Automotive
ORLY
$72.4B
$827K 0.01%
12,990
+2,865
+28% +$175K
CGBD icon
527
Carlyle Secured Lending
CGBD
$698M
$820K 0.01%
56,300
-19,000
-25% -$264K
RDY icon
528
Dr. Reddy's Laboratories
RDY
$9.82B
$815K 0.01%
64,575
-2,510
-4% -$29.3K
DCPH
529
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$813K 0.01%
+57,721
New +$826K
SKT icon
530
Tanger
SKT
$4.82B
$801K 0.01%
36,300
-2,217
-6% -$44.5K
LHX icon
531
L3Harris
LHX
$55.9B
$801K 0.01%
4,091
-81
-2% -$15.5K
BF.B icon
532
Brown-Forman Class B
BF.B
$12B
$796K 0.01%
11,913
-257
-2% -$16.4K
STEP icon
533
StepStone Group
STEP
$3.48B
$794K 0.01%
32,000
-800
-2% -$18.4K
UROY
534
Uranium Royalty Corp
UROY
$434M
$791K 0.01%
395,457
+177,917
+82% +$354K
MNKD icon
535
MannKind Corp
MNKD
$1.28B
$791K 0.01%
194,278
+20,874
+12% +$87K
PLRX icon
536
Pliant Therapeutics
PLRX
$67.5M
$788K 0.01%
43,483
+11,361
+35% +$269K
CBAY
537
DELISTED
Cymabay Therapeutics
CBAY
$785K 0.01%
71,678
+9,298
+15% +$86.6K
DIS icon
538
Walt Disney
DIS
$165B
$784K 0.01%
8,780
+3,357
+62% +$318K
ODFL icon
539
Old Dominion Freight Line
ODFL
$48.5B
$770K 0.01%
4,166
+1,430
+52% +$232K
A icon
540
Agilent Technologies
A
$39.1B
$768K 0.01%
6,387
-113
-2% -$14.4K
NICE icon
541
Nice
NICE
$5.29B
$763K 0.01%
3,696
+1,099
+42% +$227K
GIC icon
542
Global Industrial
GIC
$1.34B
$754K 0.01%
27,168
-1,658
-6% -$42.9K
VRDN icon
543
Viridian Therapeutics
VRDN
$2.13B
$754K 0.01%
+31,707
New +$813K
FLNA
544
Filana Therapeutics
FLNA
$43M
$752K 0.01%
30,687
+3,187
+12% +$76.8K
DAWN
545
DELISTED
Day One Biopharmaceuticals
DAWN
$747K 0.01%
62,561
+14,078
+29% +$184K
ENB icon
546
Enbridge
ENB
$124B
$734K 0.01%
19,758
+11,971
+154% +$456K
WIT icon
547
Wipro
WIT
$18.5B
$734K 0.01%
310,818
+4,960
+2% +$11.5K
PNT
548
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$726K 0.01%
80,186
+10,583
+15% +$93.3K
CBRL icon
549
Cracker Barrel
CBRL
$1.2B
$726K 0.01%
7,791
+2,422
+45% +$249K
CHWY icon
550
Chewy
CHWY
$8.54B
$724K 0.01%
18,334
+354
+2% +$12.3K

Similar funds

ALPS Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, ALPS Advisors held 1,049 positions worth $11.5B, up 1.7% from $11.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

ALPS Advisors's Q2 2023 filing shows 36 new, 599 increased, 353 reduced and 55 closed positions. Its largest new stake was Nextpower Inc: 131,086 shares worth $5.22M. The largest sale was Magellan Midstream Partners, L.P., an estimated $128M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q2 2023 buy was Nextpower Inc: 131,086 shares worth $5.22M.
  • ALPS Advisors added most to Hess Midstream in Q2 2023, an estimated $60.8M increase.
  • ALPS Advisors's biggest Q2 2023 reduction was Magellan Midstream Partners, L.P., cutting an estimated $128M.
  • ALPS Advisors fully exited Roivant Sciences in Q2 2023, selling an estimated $3.69M.
  • ALPS Advisors's ten largest holdings make up 54% of its $11.5B portfolio in Q2 2023.
  • ALPS Advisors opened 36 new positions and closed 55 in Q2 2023.
  • ALPS Advisors's portfolio value rose 1.7% quarter-over-quarter to $11.5B.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.